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Abstract
Background: Linkage to care after HIV diagnosis is associated with both clinical and public health benefits.
However, ensuring and monitoring linkage to care by public health departments has proved to be a difficult task.
Here, we report the usefulness of routine monitoring of CD4 T cell counts and plasma HIV viral load as measures
of entry into care after HIV diagnosis.
Methods: Since July 1, 2006, the San Francisco Department of Public Health (SFDPH) incorporated monitoring
initial primary care visit into standard HIV public health investigation for newly diagnosed HIV-infected patients in
select clinics. Entry into care was defined as having at least one visit to a primary HIV care provider after the initial
diagnosis of HIV infection. Investigators collected reports from patients, medical providers, laboratories and
reviewed medical records to determine the date of the initial health care visit after HIV diagnosis. We identified
factors associated with increased likelihood of entering care after HIV diagnosis.
Results: One -hundred and sixty new HIV-infected cases were diagnosed between July 1, 2006 and June 30, 2007.
Routine surveillance methods found that 101 of those cases entered HIV medical care and monitoring of CD4 T
cell counts and plasma HIV viral load confirmed entry to care of 25 more cases, representing a 25% increase over
routine data collection methods. We found that being interviewed by a public health investigator was associated
with higher odds of entry into care after HIV diagnosis (OR 18.86 [1.83–194.80], p = .001) compared to cases
not interviewed. Also, HIV diagnosis at the San Francisco county hospital versus diagnosis at the county municipal
STD clinic was associated with higher odds of entry into care (OR 101.71 [5.29–1952.05], p < .001).
Conclusion: The time from HIV diagnosis to initial CD4 T cell count, CD4 T cell value and HIV viral load testing
may be appropriate surveillance measures for evaluating entry into care, as well as performance outcomes for
local public health departments' HIV testing programs. Case investigation performed by the public health
department or case management by clinic staff was associated with increased and shorter time to entry into HIV
medical care.
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It is estimated that up to a third of HIV-infected patients
aware of their infection are not receiving specialized HIV
medical care in the U.S., and a similar proportion of those
receiving care do not enter medical services until reaching
a stage of advanced immunosuppression [1,2]. Clinically,
early entry into care after diagnosis is associated with bet-
ter health outcomes, as patients benefit maximally from
timely initiation of highly active antiretroviral therapy
(HAART), immunizations, and screening and prophylaxis
for opportunistic infections and sexually transmitted dis-
eases (STDs) [3]. Public health benefits of early linkage to
care include access to risk-reduction interventions, possi-
bly decreased HIV transmission due to reduced plasma
and genital HIV viral load as a result of HAART, and pos-
sibly lower health care costs [3].
While case management and referral has been advocated
as a method of decreasing unmet needs for supportive
services and increasing utilization and adherence to HIV
therapy [4,5], its role in linkage to care after HIV diagnosis
remains poorly understood. At the public health level,
collecting initial CD4 T cell counts and plasma HIV viral
loads can determine the stage of HIV infection at diagno-
sis and serve as a measure of entry into medical care.
Although several studies have used CD4 T cell count tests
or plasma HIV viral load results as markers of care, those
studies have not used provider or laboratory-reported test
results as surveillance measures to assess entry to HIV
medical care in the public health setting [2,5,6]. Surveil-
lance of laboratory reports of CD4 T cell counts and
plasma HIV viral loads could be used by public health
departments as valid surrogates for entry into HIV medical
care after diagnosis, allowing the design, evaluation, and
improvement of HIV testing and linkage to care programs.
Currently, few local public health departments are using
CD4 T cell count data collected for these purposes and
many states have not yet established mandatory labora-
tory reporting of CD4 T cell counts and plasma HIV viral
loads.
Recently, the Centers for Disease Control and Prevention
(CDC) prioritized linkage to care as a primary strategic
prevention objective of the National Advancing HIV Pre-
vention plan [3]. Current recommendations include the
report of ongoing CD4 T cell count results to the local
health jurisdiction, beginning at the time of HIV diagnosis
[3]. CD4 T cell counts and plasma HIV viral load are used
clinically to determine the stage of disease and indications
for initiating antiretroviral therapy. Those tests are com-
monly obtained on the first visit for HIV medical care.
Therefore, CD4 T cell counts and plasma HIV viral load
could potentially serve as surrogate markers to evaluate
entry into care, and determine unmet health needs in var-
ious communities.
In this report we describe the characteristics of patients
having a newly diagnosed HIV infection between July 1,
2006 and June 30, 2007 who entered into HIV medical
care. Secondly, we demonstrate the additional yield
obtained by using laboratory surveillance of CD4 T cell
tests and plasma HIV viral loads as markers for entry into
HIV medical care after initial diagnosis. Lastly, we show
the effect of having had a public health investigator inter-
view after a first positive HIV test on the likelihood of
entering medical care within 3 months of the initial HIV
diagnosis.
Methods
Public health investigation and referral to HIV medical 
care
As part of its routine public health activities, the San Fran-
cisco Department of Public Health performed HIV public
health investigation, including interview and referral to
HIV medical care in all patients newly diagnosed with HIV
infection at the San Francisco's municipal STD clinic, the
San Francisco county hospital, and 13 community-based
primary care clinics affiliated with the county public
health care system. Activities and services included assur-
ing test result disclosure; counseling, assessment and
referrals for substance use, mental health, legal, disability,
housing services; and voluntary third-party anonymous
partner notification. Public health investigators made
contact with patients through the telephone, letters, emer-
gency contacts, and home or neighborhood/shelter visits.
Patients were interviewed regarding demographics, prior
and concurrent STDs, drug use, and sex partners and prac-
tices. Interviewed patients were referred to local HIV pri-
mary care providers, both within and outside of the San
Francisco county public health care system. Patients were
also assisted in making appointments and applying for
medical insurance. All data were entered into electronic
public health records.
Documentation of entry into care
San Francisco has had name-based HIV reporting since
April 2006. Laboratories are required by law to report all
plasma HIV viral load test results to the health depart-
ment. Additionally, CD4 T cell test results are collected by
health department staff from major hospital laboratories
in San Francisco or through medical records review. Since
July 1, 2006, the SFDPH incorporated monitoring of the
initial primary care visit into standard HIV public health
investigation for newly diagnosed HIV-infected patients.
We matched data on the public health investigation inter-
view and referral to HIV medical care to the CD4 T cell
counts and plasma HIV viral load reported to the county's
HIV/AIDS Surveillance Registry using names and date of
birth of patient. When discrepant laboratory results but
same dates of specimen collection were found, we used
the HIV/AIDS Surveillance Registry results. For this analy-Page 2 of 5
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tory tests ordered on the same day of diagnosis (n = 26),
assuming a high proportion of those cases may represent
individuals with longstanding known infections who
underwent HIV testing to document status for services.
CD4 T cell counts or plasma HIV viral loads obtained at
the emergency department or during acute hospitaliza-
tion were not considered surrogates of entry to HIV pri-
mary care.
Definition of outcomes
For the purpose of this study, entry into care was defined
as having at least one visit to a primary HIV care provider
after the initial diagnosis of HIV infection. Self-reports
from patients and reports by medical providers were used
to determine the date of the initial health care visit after
HIV diagnosis. Date of first HIV diagnosis, date of first pri-
mary care visit, and date of first CD4 T cell and/or plasma
HIV viral load test were used in our analysis to determine
the time from diagnosis to entry into HIV care. We used
first dates of HIV diagnosis and primary care visit.
Statistical analysis
We used t-tests to compare days to entry into care between
different subgroups and the Z-test to compare the propor-
tions of cases who accessed care to cases who did not
access care or for whom care status was unknown. We also
identified factors associated with increased likelihood of
accessing care after HIV diagnosis by using group-wise
univariate odds ratios. To control for potential confound-
ers, a logistic regression model was created and adjusted
odds ratios (adjusted ORs) were determined. All variables
included in the models were determined a priori based on
epidemiological importance and biological plausibility.
The initial model included the following variables: sex,
sexual orientation, age category, site of testing, inter-
viewed by the SFDPH, race/ethnicity, and CD4 T cell cat-
egory. However, age, race/ethnicity, sex and sexual
orientation were not found to contribute significantly to
the model (p > .05) and were excluded from the final
model. We used STATA/IC version 10.0 (StataCorp Inc,
College Station, Texas) and SAS version 9.1 (SAS Institute,
Cary, North Carolina) for the data analyses. The Univer-
sity of California San Francisco Committee on Human
Research approved this study and waived patient consent
requirements.
Results
Between July 1, 2006 and June 30, 2007, 186 newly HIV-
infected patients were diagnosed at San Francisco's
municipal STD clinic, the San Francisco county hospital,
and affiliated community-based primary care clinics. Of
these, 26 had CD4 T cell counts and plasma HIV viral
loads ordered on the day of diagnosis and were excluded
from further analysis. Of the remaining 160 HIV-infected
patients, 150 (95%) were men or male-to-female trans-
gender; 124 (78%) reported having sex with men; 74
(48%) were white, 38 (25%) were Hispanic, and 29
(19%) were African-American. The median age was 35
years (range 18 to 81 years). Fifty-seven (36%) cases were
diagnosed by rapid HIV test and 103 (64%) by standard
HIV test; 79 (49%) were diagnosed in 2006 and 81 (51%)
in 2007; 106 (66%) were diagnosed at San Francisco's
municipal STD clinic and 54 (34%) at the San Francisco
county hospital and affiliated clinics (Table 1).
Of the 160 newly HIV-infected cases included in the anal-
ysis, 121 (76%) were interviewed by a public health inves-
tigator. One hundred and one (101 (63%) out of 160
newly HIV-infected cases) patients were initially reported
to enter HIV medical care after diagnosis by self-report or
by a health provider. Laboratory records of CD4 T cell
counts or plasma HIV viral loads corroborated the entry
into HIV care of all (100%) of those 101 patients. In addi-
tion, 25 cases were confirmed to have entered HIV medi-
cal care by having records of CD4 T cell counts or plasma
HIV viral loads, representing a 25% increase from self-
report or report by a health provider. Out of those 126
cases with confirmed entry into care, 111 (88%) accessed
care within the first 3 months after diagnosis (Figure).
The average value of the first CD4 T cell count was signif-
icantly different between cases diagnosed at San Fran-
cisco's municipal STD clinic and the San Francisco county
hospital (487.9 cells/mm3 [CI, 412.1–563.8] vs. 288.4
cells/mm3 [CI, 202.8–373.9]). After adjusting for con-
founders we found that being interviewed by a public
health investigator and being diagnosed at the San Fran-
cisco County hospital or community-based primary care
clinic were strongly associated with entry into care after
diagnosis (Table 1). Age older than 30 years was also asso-
ciated with accessing HIV care within the first 3 months
after diagnosis; however, it did not reach statistical signif-
icance (Table 1).
Discussion
California requires laboratory reporting of plasma HIV
viral load test results. The San Francisco Department of
Public Health acquires CD4 T cell count information
through medical record review and voluntary laboratory
reporting. By routine surveillance of CD4 T cell counts
and plasma HIV viral loads on patients newly diagnosed
with HIV infection, we were able to document linkage to
care in 25% more patients than by patient or provider
report. Similarly, time to accessing care after HIV diagno-
sis was documented in those patients. Consistent with
prior studies suggesting that a significant proportion of
newly diagnosed HIV-infected patients are diagnosed late
in the course of their disease, 19% of the HIV-infected
cases who had CD4 T cell counts and plasma HIV viralPage 3 of 5
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consistent with an AIDS diagnosis [1].
About 20–30% of HIV-infected patients who eventually
enter care have a delay in entering care [2]. However, out-
reach and public health investigation has been found to
increase the likelihood of entering and maintaining pri-
mary care [4,6,7]. In our sample, 79% (126 out of 160
newly diagnosed HIV-infected cases) of cases had con-
firmed entry into HIV care after diagnosis and 88% (111
out of 126 cases with confirmed entry into care) entered
care within the first 3 months after diagnosis. We found
that newly HIV-infected patients interviewed by public
health investigators were more likely to access HIV medi-
cal care after diagnosis compared to non-interviewed
cases. Interviews and investigations performed by public
health staff led to an increased yield in the report of CD4
T cell counts and plasma HIV viral loads when compared
to HIV/AIDS Surveillance Registry laboratory reports
alone.
Importantly, and contrary to prior studies, we found that
being diagnosed at the San Francisco county hospital and
other community-based primary care clinics was strongly
associated with entering care after HIV diagnosis when
compared to patients diagnosed at the San Francisco
municipal STD clinic [5,8]. Although the reasons for this
finding remain unclear, it may reflect various factors
Table 1: Characteristics of newly diagnosed HIV-infected cases with confirmed entry into care, San Francisco Department of Public 
Health, July 2006 to June 2007 (N = 160)
Confirmed
(n = 126)




P value Univariate 
OR




Male 117 (93%) 34 (100%) NS 0.30 (0.04 – 2.56) 0.28
Women 9 (7%) 0 NS
Self-reported sexual 
orientation
Men who have sex with men 93 (74%) 31 (91%) 0.05 0.22 (0.07 – 0.66) <0.01
Race/ethnicity
White 61 (48%) 13 (38%) NS
Black 22 (17%) 7 (21%) NS 1.22 (0.48 – 3.11) 0.68
Hispanic 30 (23%) 8 (24%) NS 1.14 (0.49 – 2.64) 0.76
Asian 7 (6%) 4 (12%) NS 0.81 (0.22 – 3.02) 0.76
Age categories
Less or equal to 25 years 22 (17%) 12 (35%) NS
26 to 35 years 39 (31%) 11 (32%) NS 1.32 (0.53 – 3.27) 0.56
36 to 45 years 45 (36%) 7 (21%) NS 1.68 (0.67 – 4.23) 0.27
Older than 45 years 20 (16%) 4 (12%) NS 1.86 (0.59 – 5.89) 0.29
Site of diagnosis
Municipal STD clinic 74 (59%) 32 (94%) <0.01
County hospital 37 (29%) 0 <0.001 27.6 (3.64 – 208.84) 0.001 101.71 (5.29 – 1952.05) <0.001
Community clinics 12 (10%) 1 (3%) NS 9.2 (1.15 – 73.34) 0.04 18.53 (0.75 – 457.98) 0.07
Other 3 (2%) 1 (3%) NS 2.3 (0.23 – 22.84) 0.48
Initial CD4 T cell count
Less or equal to 200 30 (19%) NA NA
Between 200 and 500 21 (13%) NA NA 7.05 (2.80 – 17.71) <0.001 5.99 (1.75 – 20.44) <0.01
Higher than 500 66 (48%) NA NA 13 (3.66 – 46.15) <0.001 7.61 (1.71 – 33.75)
Interviewed by the SFDPH 88 (70%) 33 (97%) NS 1.86 (0.87 – 3.94) 0.11 18.86 (1.83 – 194.80) 0.001
First primary care visit within 
3 months of diagnosis
111 (88%) NA NA 20.88 (8.85 – 49.25) <0.001 7.44 (2.45 – 22.57) <0.001
NS = Not significant, NA = Not applicablePage 4 of 5
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factors related to reasons for HIV testing. In addition, the
San Francisco county hospital has initiated a multidisci-
plinary program to assure that all HIV-infected patients
diagnosed at the hospital receive intensive care and public
health investigation. Although the design of this study
does not allow exploration of the effect of that hospital-
based program on linkage to care, it seems likely that it
played a major role in the success achieved by that site.
Several limitations of our findings should be acknowl-
edged. The purpose of our study was to describe the char-
acteristics of newly diagnosed cases of HIV infection and
the usefulness of CD4 T cell counts and plasma HIV viral
loads as surrogate measures for entry into care after the
initial HIV diagnosis. Therefore, we excluded patients who
had CD4 T cell counts and plasma HIV viral loads on the
same day of HIV diagnosis, assuming that these may rep-
resent individuals with longstanding infections who
underwent HIV testing to document status for services.
Although it seems unlikely, by excluding these patients we
might have excluded a group of patients who were linked
to care on the same day of HIV diagnosis. Given that we
defined entry into care as having had at least one visit to
an HIV-care provider, this study does not allow any con-
clusions regarding maintenance of care after the initial
visit. The use of multiple approaches to determine our pri-
mary outcome (entry into care) might have introduced
biases to the analysis. Information provided by patients
and health care providers interviewed by public health
investigators are subject to social desirability and recall
bias. Due to the observational nature of this study, our
conclusions are subject to the limitations of observational
studies and we cannot infer causality. Inaccuracy and
incompleteness of documentation in the patients' charts
and laboratory records, delayed reporting in surveillance
data, as well as variation in the efforts invested by differ-
ent public health investigators to obtain those data might
have decreased the accuracy of our data or introduced
biases.
Conclusion
With the advent of expanded HIV testing, initial CD4 T
cell count and plasma HIV viral load surveillance data can
help local health departments determine when HIV-
infected persons are being linked to care and the stage of
HIV infection at the time of diagnosis. The time from HIV
diagnosis to initial CD4 T cell count and plasma HIV viral
load may be an appropriate surveillance measure for
marking entry into care, as well as a performance measure
for public health departments' HIV prevention and testing
programs.
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